Gvoke (glucagon) is a prescription drug that’s used to treat severely low blood sugar in certain people with diabetes. Gvoke comes as a liquid solution that’s given as an injection under the skin.
Gvoke (glucagon) is a brand-name drug prescribed for extremely low blood sugar from diabetes in adults and some children. Gvoke comes as a subcutaneous injection that’s used as needed. Gvoke is ...
Xeris Pharmaceuticals, a specialty pharmaceutical company, is introducing Gvoke HypoPen (glucagon injection) for the treatment of severe hypoglycemia in adults and children with diabetes ages 2 years ...
Approximately 78% of commercially insured and Medicare lives have unrestricted access to Gvoke HypoPen at launch Easy to use: premixed and ready-to-go A reliable method of delivery: 99% of people were ...
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology ...
Diabetes patients have long relied on complex glucagon kits to treat hypoglycemia. Late last summer, Xeris Pharmaceuticals aimed to change that with the first FDA-approved prefilled syringe. Now, its ...
The new Gvoke Kit formulation is available as a 1mg/0.2mL single-dose vial and syringe kit. Gvoke ® Kit is now available for the treatment of severe hypoglycemia in adult and pediatric patients with ...
Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal radiologic exams, expanding the product's sales base beyond diabetic patients ...
Credit: Getty Images. The FDA has approved the new Gvoke® Kit formulation for the treatment of severe hypoglycemia in patients with diabetes 2 years of age and older. The Food and Drug Administration ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc. ® is pleased to announce the commercial ...
First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results